SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending after reporting stronger-than-expected Q3 earnings, fueled by significant cloud and AI infrastructure growth and a raised FY2027 revenue outlook, leading the community to anticipate a substantial rebound and potential short squeeze. Its surging remaining performance obligations, largely supported by customer-funded AI capacity, are seen as validating its AI strategy against prior bearish sentiment.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Round Rock, TX.

TSS Inc

TSS Inc. (TSSI) is trending after a substantial Q4 earnings beat, driven by strong growth in its AI-focused Systems Integration business and an extended partnership with Dell amid escalating AI infrastructure demand. The community is actively discussing the company's crucial role in data center expansion and high short interest, anticipating significant upside.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics trends with robust Q4 results and a raised 2026 outlook, driven by expanding delivery partnerships and a strategic acquisition into healthcare robotics, all while high short interest and recent praise from NVIDIA's CEO fuel intense community discussion.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending as it rapidly expands its autonomous mobility ecosystem, driven by new robotaxi partnerships with Amazon's Zoox and Wayve, the launch of Uber Air with Joby, and the strategic acquisition of parking app SpotHero. The community sees these moves, alongside investments in EV charging infrastructure, as key to solidifying its future market dominance despite ongoing market fluctuations.

The Campbell's Co. engages in the business of manufacturing and marketing food and beverage products. It operates under the Meals and Beverages, and Snacks segments. The Meals and Beverages segment includes soup, meals, and beverage products in retail and foodservice. The Snacks segment offers cookies, crackers, bakery, and frozen products. The company was founded by Joseph Campbell and Abraham Anderson in 1869 and is headquartered in Camden, NJ.

Campbells Co (The)

Campbell Soup Co.

Campbell Soup Co. is heavily discussed following a disappointing earnings report and reduced full-year guidance, which has intensified concerns over debt and weak consumer demand. While many express strong bearish sentiment and speculate on further declines to multi-decade lows, others highlight the stock's current valuation as "insanely cheap" for its dividend and strong performing brands like Rao's, anticipating a potential rebound.

CitroTech, Inc. is an integrated environmental service company, which engages in the provision of field services, remediation transportation, and EHS compliance services. It also offers on-site technical services, on-site and off-site treatment for hazardous and non-hazardous waste. The company was founded on March 14, 1990 and is headquartered in Cheyenne, WY.

CitroTech Inc.

CitroTech (CITR) is gaining significant traction and trading volume following its presentation at an investor conference, where its unique EPA Safer Choice-certified fire retardant technology was showcased. Discussions are focusing on the company's low float and strong regulatory moat in the context of increasing demand for wildfire prevention solutions.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is a hot topic following a significant $2 billion strategic investment from NVIDIA and the approval of a massive gigawatt-scale AI factory in Independence, Missouri, with the community noting that customer upfront payments further underscore its robust position and growth potential in the AI infrastructure sector.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is trending amid high anticipation for crucial DRAM wafer test results, fueling intense speculation within the community about a major licensing deal or potential buyout, particularly involving Applied Materials, to enhance performance and power efficiency in next-generation AI chips; a recent $25 million direct offering at $5 a share has, however, created divided opinions among investors regarding dilution versus institutional validation.

Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut in 2003 and is headquartered in Jerusalem, Israel.

Brainsway Ltd - ADR

Brainsway Ltd.

BrainsWay is trending following strong financial results and multiple FDA clearances for its Deep TMS system, including an accelerated depression treatment protocol and expanded indication for adolescents. The community is actively discussing how Optum's broadened coverage significantly enhances market access and adoption for these innovative neurostimulation therapies.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is highly discussed as investors weigh fresh geopolitical concerns over potential Strait of Hormuz disruptions and upcoming inflation data against positive news of strategic oil reserve releases and strong tech sector earnings, fueling community debate on underlying market direction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>While Microbot's corporate headquarters are in the U.S., the heart of its technical development is its facility in the Caesarea Business and Industrial Park in Israel.</li><li>The company said it maintains sufficient Liberty system inventory in the U.S. to support current customers and is building additional stock to meet anticipated demand.</li></ul>Israel-founded Microbot Medical Inc. (MBOT) said on Tuesday that it is not experiencing any business disruption due to geopolitical events but is actively building additional stock in the U.S. to meet anticipated demand for its Liberty system.Shares of the company, however, traded 3% lower at the time of writing.<h2 class="st-heading-2">Microbot’s Assurance</h2>Microbot <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2026/03/03/3248415/0/en/Microbot-Medical-Confirms-Continued-Operational-and-Commercial-Stability-Amid-Current-Geopolitical-Event.html">said</a> that it is not experiencing any disruption in either the U.S. or Israel with all personnel continuing to operate as usual and both internal operations and the lead manufacturing partner remaining fully functional.The FDA approved Microbot’s Liberty Endovascular Robotic System, a single-use, remotely operated robotic system for peripheral endovascular procedures, in September 2025. The company said that its commercial focus is now on the U.S. Market which is managed by its U.S.-based commercial team in Hingham.“This ensures uninterrupted service, reliable distribution, and continued advancement of the limited market release of the LIBERTY System as planned,” the company said. It added that the company maintains sufficient inventory in the U.S. to support current customers and is building additional stock to meet anticipated demand. The additional stock is being built through the company's U.S.-based third party logistics partner, it said.“The Company is closely monitoring the situation in the Middle East to ensure the ongoing well-being of its employees and to ensure uninterrupted support for customers, reinforcing its commitment to operational excellence,” it added.While Microbot's corporate headquarters are in the U.S., the heart of its technical development is its facility in the Caesarea Business and Industrial Park in Israel.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, the retail sentiment around MBOT stock stayed within the ‘bullish’ territory over the past 24 hours, while message volume remained at ‘high’ levels.<a href="https://stocktwits.com/symbol/MBOT">MBOT stock</a> has risen 76% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/mdb-stock-sees-biggest-single-day-decline-on-record-wall-street-cuts-price-targets-on-slower-atlas-growth-and-cautious-outlook/cZdekxtRIPK">MDB Stock Sees Biggest Single-Day Decline On Record: Wall Street Cuts Price Targets On Slower Atlas Growth And Cautious Outlook</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Global stock market chart and trading board - stock photo

MBOT Stock Falls As Investors Ponder Impact Of Geopolitical Tensions On Israel-Founded Company

Microbot said on Tuesday that it is not experiencing any disruption in either the U.S. or Israel with all personnel continuing to operate as usual. 

Equity

Microbot said on Tuesday that it is not experiencing any disruption in either the U.S. or Israel with all personnel continuing to operate as usual. 


Microbot Medical (NASDAQ:MBOT) Stock Price Crosses Above 200 Day Moving Average - Here's What Happened

Microbot Medical (NASDAQ:MBOT) Share Price Crosses Above Two Hundred Day Moving Average - What's Next...

$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab

Markets are heading into the close, with a series of high-impact corporate developments that are reshaping narratives across defense, biotech, cybersecurity, robotics, and enterprise software. Several small- and mid-cap names are flashing disconnects between fundamentals and valuation, in some cases dramatically so. NAPC Defense (OTCID:BLIS) announced $38M in new and recently finalized U.S. government task orders

Microbot Medical (NASDAQ:MBOT) Posts Earnings Results, Misses Expectations By $0.01 EPS

Microbot Medical (NASDAQ:MBOT - Get Free Report) released its quarterly earnings data on Wednesday. The biotechnology company reported ($0.07) earnings per share for the quarter, missing the...

Down 28.2% in 4 Weeks, Here's Why You Should You Buy the Dip in Microbot Medical (MBOT)

Microbot Medical (MBOT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Stereotaxis Rolls Out Synchrony System in EU and Files for FDA Approval

STXS expands its digital surgery vision with the EU launch of its Synchrony System and an FDA submission for market entry.

All You Need to Know About Microbot Medical (MBOT) Rating Upgrade to Buy

Microbot Medical (MBOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System

MBOT shares rise as FDA clears its LIBERTY robotic system, paving the way for U.S. market entry and fueling strong investor momentum.

Microbot Shares Rise as New U.S. Patent Expands LIBERTY System Market

MBOT's new U.S. patent boosts the LIBERTY system's flexibility, expanding its U.S. market reach to over six million annual procedures.

Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock?

Microbot Medical, Inc. is a pre-clinical medical device company engaged in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

MBOT
Microbot Medical Inc

Feed

News

Sentiment

Fundamentals

Info

Latest MBOT News

MBOTMicrobot Medical Inc